Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Interventional × alectinib × Clear all

Phase

Phase 2 26 Phase 1/2 10 Phase 3 9 Phase 2/3 3 Phase 1 3 Phase NA 1 Phase EARLY_PHASE1 1 Phase 4 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lung Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

Dexamethasone 56 Metformin 50 Cyclophosphamide 47 Saline Solution 39 Cytarabine 37 Cisplatin 36 Zoledronic Acid 34 Letrozole 34 Carboplatin 33 Sodium Chloride 32 Bupivacaine 31 Docetaxel 30 Bevacizumab 30 Vincristine 29 Methotrexate 29 Fluorouracil 28 Propofol 27 Capecitabine 27 Fentanyl 26 Doxorubicin 26 Rituximab 25 Drug Therapy 25 Dexmedetomidine 25 Prednisone 23 Paclitaxel 23 Oxaliplatin 21 Morphine 21 Gemcitabine 21 Radiotherapy 19 Prednisolone 19

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05525338 2024-05-13

ADAPT ALEC

University Medical Center Groningen

Phase 4 Recruiting

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡